Showing results (31-40 of 347) with videos related to

Sort By:
Pageof 35
Urologia Internationalis|May 9, 2006
The physiological function of the urothelium--more than a simple barrierMassimo Lazzeri
Urologia|October 27, 2015
New horizons for GAG therapy in the management of urothelial damageMassimo Lazzeri
European Urology|April 5, 2011
Robot-assisted uretero-ureterostomy for iatrogenic lumbar and iliac ureteral stricture: technical details and preliminary clinical resultsNicolòmaria Buffi, Andrea Cestari, Giovanni Lughezzani, et al.
Neurourology and Urodynamics|March 8, 2012
The relationship between continence and perineal body tone before and after radical prostatectomy: a pilot studyLorenzo Rigatti, Antonia Centemero, Giovanni Lughezzani, et al.
Frontiers in Oncology|June 6, 2022
Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective TrialRoberto Contieri, Giovanni Lughezzani, Nicolò Maria Buffi, et al.
European Urology Oncology|June 1, 2021
Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non-muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) ExperienceRoberto Contieri, Marco Paciotti, Giovanni Lughezzani, et al.
European Urology Focus|November 11, 2018
Early Catheter Removal After Robot-assisted Radical Prostatectomy: Results from a Prospective Single-institutional Randomized Trial (Ripreca Study)Giuliana Lista, Giovanni Lughezzani, Nicolò Maria Buffi, et al.
Korean Journal of Urology|July 22, 2014
Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literatureAlberto Abrate, Giovanni Lughezzani, Giulio Maria Gadda, et al.
European Urology|April 13, 2011
Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical settingGiorgio Guazzoni, Luciano Nava, Massimo Lazzeri, et al.
Urologic Oncology|June 29, 2021
The use of 29 MHz transrectal micro-ultrasound to stratify the prostate cancer risk in patients with PI-RADS III lesions at multiparametric MRI: A single institutional analysisPier Paolo Avolio, Giovanni Lughezzani, Marco Paciotti, et al.
Pageof 35